Background: Cardiovascular disease (CVD) is the first cause of mortality worldwide, with all the healthcare systems facing this very challenging issue. Aspirin continues to be the major …
MK Freynhofer, SC Gruber, EL Grove… - Thrombosis and …, 2015 - thieme-connect.com
Platelets are key players in atherothrombosis. Antiplatelet therapy comprising aspirin alone or with P2Y 12-inhibitors are effective for prevention of atherothrombotic complications …
JW Zhang, WW Liu, TA McCaffrey, XQ He… - … Interventions in Aging, 2017 - Taylor & Francis
Objectives Previous studies have illustrated the link between high on-aspirin platelet reactivity (HAPR) with increasing thrombotic risks. The aim of our study was to investigate …
M Horyniecki, B Łącka-Gaździk, E Niewiadomska… - Arch Intern …, 2018 - ppm.edu.pl
RESULTS No significant differences were observed in the prevalence of HOPR between patients with and without CKD. Patients with CKD and HOPR measured by ASPItest had …
Background and objectives: Recent randomized trials of oral antithrombotic drugs with atrial flutter (AFL) excluded patients with renal impairment because of their increased risk of …
Демографические изменения, происходящие в последние десятилетия в Российской Федерации, как и во многих других странах мира, характеризуются увеличением доли …
A szervátültetés története, szervek és testrészek egyik emberből, másik emberbe, vagy állatból emberbe történő átvitele évezredekre nyúlik vissza. Az egyik legkorábbi és talán a …